Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solutionAlembic Pharmaceuticals Ltd has obtained final approval from the US FDA for its generic Bromfenac ophthalmic solution, used to treat postop...
Just coming to our own in India; confident of growing our US business in next fiscal year: Lupin managementLupin's margin guidance remains around 19.5-20.5%. The company attributes its success to the pivot to complex products, cost-led initiative...
Lupin gets EIR for Pithampur Unit-2, paves way for resolving warning letterThe EIR represents the closure of the inspection, and also paves the way for possible lifting of warning letters on the facility imposed by...